Tau pathology in Alzheimer disease and other tauopathies

Iqbal, Khalid, del C. Alonso, Alejandra, Chen, She, Chohan, M. Omar, El-Akkad, Ezzat, Gong, Cheng-Xin, Khatoon, Sabiha, Li, Bin +4 more·2005·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Cited by (999)

Items 201–300 of 999

  1. The Link Between Physical Activity and Cognitive Dysfunction in Alzheimer Disease
    Cristy Phillips, Mehmet Akif Baktir, Devsmita Das, Bill Lin, Ahmad Salehi · 2015 · Physical Therapy
  2. Imaging Amyloid‐β Membrane Interactions: Ion‐Channel Pores and Lipid‐Bilayer Permeability in Alzheimer's Disease
    John H. Viles · 2023 · Angewandte Chemie International Edition
  3. Cerebrospinal fluid tau, Aß, and phosphorylated tau protein for the diagnosis of Alzheimer's disease
    Patrizia Formichi, Carla Battisti, Elena Radi, Antonio Federico · 2006 · Journal of Cellular Physiology
  4. Cellular stress response, sirtuins and UCP proteins in Alzheimer disease: role of vitagenes
    Carolin Cornelius, Angela Trovato Salinaro, Maria Concetta Scuto, Vincenzo Fronte, Maria Teresa Cambria, Manuela Pennisi, Rita Bella, Pietro Milone, Antonio Graziano, Rosalia Crupi et al. · 2013 · Immunity & Ageing
  5. SIRT1 facilitates amyloid beta peptide degradation by upregulating lysosome number in primary astrocytes
    Minzhe Li, Jianguo Ji, Liang-Jun Zheng, Jian Shen, Xinya Li, Qi Zhang, Xue Bai, Qingsong Wang · 2018 · Neural Regeneration Research
  6. Formaldehyde, Epigenetics, and Alzheimer’s Disease
    Fei Wang, Danqi Chen, Peipei Wu, Catherine B. Klein, Chunyuan Jin · 2019 · Chemical Research in Toxicology
  7. Melatonin Therapy in Patients with Alzheimer’s Disease
    Daniel Pedro Cardinali, Daniel Eduardo Vigo, Natividad Olivar, María Vidal, Luis Ignacio Brusco · 2014 · Antioxidants
  8. Quercetin Increases Mitochondrial Biogenesis and Reduces Free Radicals in Neuronal SH-SY5Y Cells
    Chia-Ling Ho, Ning-Jo Kao, Ching-I Lin, Tzu-Wen Cross, Shyh‐Hsiang Lin · 2022 · Nutrients
  9. Methylglyoxal Induces Tau Hyperphosphorylation via Promoting AGEs Formation
    Xiaohong Li, Jiazhao Xie, Xia Jiang, Bing-Ling Lv, Xiangshu Cheng, Lailing Du, Jia Yu Zhang, Jian‐Zhi Wang, Xinwen Zhou · 2012 · NeuroMolecular Medicine
  10. Role of Hypoxia Inducible Factor-1α in Alzheimer’s Disease
    Yangyang Wang, Zhenting Huang, Minghao Yuan, Jing Feng, Ruo-Lan Cai, Qian Zou, Yinshuang Pu, Shengyuan Wang, Fei Chen, Wenmin Yi et al. · 2021 · Journal of Alzheimer s Disease
  11. CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
    Vasileios T. Papaliagkas, Kallirhoe Kalinderi, Patroklos K Vareltzis, Despina Μoraitou, Theodora Papamitsou, Maria Chatzidimitriou · 2023 · International Journal of Molecular Sciences
  12. The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases
    Delsuz Rezaee, Fatemeh Saadatpour, Nayyereh Akbari, Anahita Zoghi, Sajad Najafi, Parisa Beyranvand, Fahimeh Zamani Rarani, Mohammad Amin Rashidi, Saeid Bagheri‐Mohammadi, Mohammad Bakhtiari · 2023 · Ageing Research Reviews
  13. Phospholipase C-γ1 involved in brain disorders.
    H. Jang, Y. Yang, Jung Kuk Kim, J. Choi, Young-kyo Seo, Y. Lee, Jeung-Eun Lee, S. Ryu, P. Suh · 2013 · Advances in Biological Regulation
  14. Tacrine–propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer’s disease
    Fei Mao, Jianheng Li, Hui Wei, Ling Huang, Xingshu Li · 2015 · Journal of Enzyme Inhibition and Medicinal Chemistry
  15. Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?
    K. A. Jellinger, Bernd Janetzky, Johannes Attems, Elisabeth Kienzl · 2008 · Journal of Cellular and Molecular Medicine
  16. Regulation of phosphorylation of tau by cyclin‐dependent kinase 5 and glycogen synthase kinase‐3 at substrate level
    Amitabha Sengupta, Michal Novák, Inge Grundke, Khalid Iqbal · 2006 · FEBS Letters
  17. A Role of Ginseng and Its Constituents in the Treatment of Central Nervous System Disorders
    Natasya Trivena Rokot, Timothy Sean Kairupan, Kai‐Chun Cheng, Joshua Runtuwene, Nova Hellen Kapantow, Marie S. Amitani, Akinori Morinaga, Haruka Amitani, Akihiro Asakawa, Akio Inui · 2016 · Evidence-based Complementary and Alternative Medicine
  18. 14-3-3 Proteins and regulation of cytoskeleton
    Nikolai N. Sluchanko, Nikolai B. Gusev · 2010 · Biochemistry (Moscow)
  19. The role of inflammatory processes in Alzheimer’s disease
    Gerard Joey Broussard, Jennifer O. Mytar, Rung‐chi Li, Gloria J. Klapstein · 2012 · Inflammopharmacology
  20. Butanol extract of Ecklonia cava prevents production and aggregation of beta-amyloid, and reduces beta-amyloid mediated neuronal death
    Il‐Jun Kang, Young Eun Jeon, Xing Fu Yin, Jin‐Sik Nam, Sang Guan You, Myo Soon Hong, Bong Geom Jang, Min-Ju Kim · 2011 · Food and Chemical Toxicology
  21. Recent advances in biosensors for neurodegenerative disease detection
    Hashwin V. S. Ganesh, Ari M. Chow, Kağan Kerman · 2016 · TrAC Trends in Analytical Chemistry
  22. Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma
    Hussein Abou‐Abbass, Hadi Abou‐El‐Hassan, Hisham F. Bahmad, Kazem Zibara, Abir Zebian, Rabab Youssef, Joy N. Ismail, Rui Zhu, Shiyue Zhou, Xue Dong et al. · 2016 · Electrophoresis
  23. Diagnosis and Management of Neuropsychiatric Symptoms in Alzheimer’s Disease
    D. Wolinsky, K. Drake, Jolene R. Bostwick · 2018 · Current Psychiatry Reports
  24. Hyperphosphorylation Results in Tau Dysfunction in DNA Folding and Protection
    Yang Lü, Hai-Jin He, Jun Zhou, Jun-Ye MIAO, Jing Lü, Ying-Ge He, Rong Pan, Wei Yan, Ying Min Liu, Rongqiao He · 2013 · Journal of Alzheimer s Disease
  25. Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?
    Debby Van Dam, Yannick Vermeiren, Alain D. Dekker, Petrus J.W. Naudé, Peter Paul De Deyn · 2016 · Current Alzheimer Research
  26. The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review
    Lianne A. Hulshof, Danny van Nuijs, Elly M. Hol, Jinte Middeldorp · 2022 · Frontiers in Cellular Neuroscience
  27. The Involvement of Lipids in Alzheimer's Disease
    Wei Ling Florence Lim, Ian James Martins, Ralph Nigel Martins · 2014 · Journal of genetics and genomics/Journal of Genetics and Genomics
  28. Occupational-like organophosphate exposure disrupts microglia and accelerates deficits in a rat model of Alzheimer’s disease
    Jaymie R. Voorhees, Matthew T. Remy, Claire M Erickson, Laura M. Dutca, Daniel Jay Brat, Andrew A. Pieper · 2019 · npj Aging and Mechanisms of Disease
  29. Integrative Brain Transcriptome Analysis Links Complement Component 4 and HSPA2 to the APOE ε2 Protective Effect in Alzheimer Disease
    R. Panitch, Jun-Ming Hu, J. Chung, Cong-Cong Zhu, Gaoyuan Meng, Weiming Xia, David A. Bennett, K. Lunetta, T. Ikezu, R. Au et al. · 2020 · Molecular Psychiatry
  30. Blood-based immunoassay of tau proteins for early diagnosis of Alzheimer's disease using surface plasmon resonance fiber sensors
    Truong Thi Vu Nu, Nhu Hoa Thi Tran, Eunjoo Nam, Tan Tai Nguyen, Won Jung Yoon, Sungbo Cho, Jungsuk Kim, Keun-A Chang, Heongkyu Ju · 2018 · RSC Advances
  31. Gene expression data analysis using Hellinger correlation in weighted gene co-expression networks (WGCNA)
    Tianjiao Zhang, Garry Wong · 2022 · Computational and Structural Biotechnology Journal
  32. From tau to toxicity: Emerging roles of NMDA receptor in Alzheimer's disease
    Muhammad Omar Chohan, Khalid Iqbal · 2006 · Journal of Alzheimer s Disease
  33. Novel tacrine–ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity
    Fei Mao, Jianwen Chen, Qi Zhou, Zonghua Luo, Ling Huang, Xingshu Li · 2013 · Bioorganic & Medicinal Chemistry Letters
  34. Calpain Dysregulation in Alzheimer’s Disease
    Adriana Ferreira · 2012 · ISRN Biochemistry
  35. Filamentous Aggregates Are Fragmented by the Proteasome Holoenzyme
    Rachel Cliffe, Jason C. Sang, Franziska Kundel, Daniel J. Finley, David Klenerman, Yu Ye · 2019 · Cell Reports
  36. Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
    Sebastian Scott Oakley, Mahmoud Bukar Maina, Karen E. Marshall, Youssra K. Al‐Hilaly, Charlie Harrington, Claude M. Wischik, Louise C. Serpell · 2020 · Frontiers in Neurology
  37. Increased CDK5 Expression in HIV Encephalitis Contributes to Neurodegeneration via Tau Phosphorylation and Is Reversed with Roscovitine
    Christina Patrick, Leslie A. Crews, Paula Desplats, Wilmar Dumaop, Edward M. Rockenstein, Cristian L. Achim, Ian Everall, Eliezer Masliah · 2011 · American Journal Of Pathology
  38. Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease
    Gustavo Basurto‐Islas, Julie Blanchard, Yunn Chyn Tung, José Ramón Fernández, Michael V. Voronkov, Maxwell B. Stock, Sherry Zhang, Jeffry B. Stock, Khalid Iqbal · 2014 · Neurobiology of Aging
  39. Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial
    Khalid Iqbal, Xiaochuan Wang, Julie Blanchard, Fei Liu, Cheng‐Xin Gong, Inge Grundke · 2010 · Biochemical Society Transactions
  40. ALS-Related Mutant SOD1 Aggregates Interfere with Mitophagy by Sequestering the Autophagy Receptor Optineurin
    Yeong Jin Tak, Ju-Hwang Park, Hyangshuk Rhim, Seongman Kang · 2020 · International Journal of Molecular Sciences
  41. Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease
    Isidró Ferrer, Pol Andrés‐Benito, Karina Ausín, Reinald Pamplona, José Antonio del Rı́o, Joaquín Fernández‐Irigoyen, Enrique Santamaría · 2021 · Brain Pathology
  42. Transcriptome profiling in neurodegenerative disease
    Eliza Courtney, Shan Kornfeld, Karolina Janitz, Michael Janitz · 2010 · Journal of Neuroscience Methods
  43. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways
    Jiang-Ping Hu, Jingwei Xie, Chunyan Wang, Tao Wang, Xu Wang, Siling Wang, Weiping Teng, Zhan‐You Wang · 2011 · Brain Research Bulletin
  44. Novel D–A–D based near-infrared probes for the detection of β-amyloid and Tau fibrils in Alzheimer's disease
    Yuying Li, Kan Wang, Kaixiang Zhou, Wentao Guo, Bin Dai, Yi Liang, Jiapei Dai, Mengchao Cui · 2018 · Chemical Communications
  45. Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches
    Niyanta N. Kumar, Michelle E. Pizzo, Geetika Nehra, Brynna Wilken-Resman, Sam Boroumand, Robert G. Thorne · 2018 · Bioconjugate Chemistry
  46. Ghrelin in Alzheimer’s disease: Pathologic roles and therapeutic implications
    Seong Gak Jeon, Sang Bum Hong, Yunkwon Nam, Jungyeon Tae, Anji Yoo, Eun Ji Song, Kun Il Kim, Dongje Lee, Junyong Park, Sang Min Lee et al. · 2019 · Ageing Research Reviews
  47. Plasma rich in growth factors (PRGF-Endoret) reduces neuropathologic hallmarks and improves cognitive functions in an Alzheimer's disease mouse model
    Eduardo Anitua, Consuelo Pascual, Desireé Antequera, Marta Bolós, Sabino Padilla, Gorka Orive, Eva Carro · 2014 · Neurobiology of Aging
  48. Anti-Alzheimer’s Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential
    Md. Tanvir Kabir, Md. Sahab Uddin, Philippe Jeandet, Talha Bin Emran, Saikat Mitra, Ghadeer Mohsen Albadrani, Amany Ahmed Sayed, Mohamed M. Abdel‐Daim, Jesús Simal‐Gándara · 2021 · Marine Drugs
  49. Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity
    Yunpeng Huang, Zhihao Wu, Bing Zhou · 2015 · Cellular and Molecular Life Sciences
  50. Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A
    Xifei Yang, Ying Yang, Zhengqi Fu, Yin Li, Jing Bo Feng, Jinzhuo Luo, Qiuyue Zhang, Qun Wang, Qing Tian · 2010 · Journal of Psychopharmacology
  51. Using Topological Indices to Predict Anti-Alzheimer and Anti-Parasitic GSK-3 Inhibitors by Multi-Target QSAR in Silico Screening
    Isela García, Yagamare Fall, Generosa Gómez · 2010 · Molecules
  52. Expression of Tau Pathology-Related Proteins in Different Brain Regions: A Molecular Basis of Tau Pathogenesis
    Wen Hui Hu, Feng Wu, Yanchong Zhang, Cheng‐Xin Gong, Khalid Iqbal, Fei Liu · 2017 · Frontiers in Aging Neuroscience
  53. Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
    Johan Gobom, Andréa Lessa Benedet, Niklas Mattsson, Laia Montoliu‐Gaya, Nina Schultz, Nicholas James Ashton, Shorena Janelidze, Stijn Servaes, Mathias Sauer, Tharick Ali Pascoal et al. · 2022 · Molecular Neurodegeneration
  54. Pharmacotherapeutic targets in Alzheimer's disease
    Yif'at Biran, Colin Louis Masters, Kevin Jeffrey Barnham, Ashley Ian Bush, Paul Anthony Adlard · 2008 · Journal of Cellular and Molecular Medicine
  55. Characterization of the Human Cerebrospinal Fluid Phosphoproteome by Titanium Dioxide Affinity Chromatography and Mass Spectrometry
    Justyna M.C. Bahl, Søren Skov Jensen, Martin R. Larsen, Niels H. H. Heegaard · 2008 · Analytical Chemistry
  56. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease.
    N. el Kadmiri, I. Slassi, B. El Moutawakil, S. Nadifi, Artavazd Tadevosyan, A. Hachem, Abdelaziz Soukri · 2014 · Pathologie et biologie
  57. Calcium in the initiation, progression and as an effector of Alzheimer’s disease pathology
    Kim N. Green · 2009 · Journal of Cellular and Molecular Medicine
  58. The Role of Serotonin Receptors in Alzheimer’s disease
    Malte Butzlaff, Evgeni G. Ponimaskin · 2016 · Russian Agency for Digital Standardization
  59. Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review
    Daniela Malafaia, Hélio M. T. Albuquerque, Artur M. S. Silva · 2021 · European Journal of Medicinal Chemistry
  60. The role of β-amyloid peptide in neurodegenerative diseases
    Alexander V. Maltsev, Simon M. Bystryak, Oxana V. Galzitskaya · 2011 · Ageing Research Reviews
  61. Intraventricular infusion of quinolinic acid impairs spatial learning and memory in young rats: a novel mechanism of lead-induced neurotoxicity
    Abdur Rahman, M.S. Rama Rao, Khalid M. Khan · 2018 · Journal of Neuroinflammation
  62. Cyclic Peptides as Inhibitors of Amyloid Fibrillation
    Jinghui Luo, Jan Pieter Abrahams · 2014 · Chemistry - A European Journal
  63. Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer’s disease
    Tropea, Maria Rosaria, Gulisano, Walter, Vacanti, Valeria, Arancio, Ottavio, Puzzo, Daniela, Palmeri, Agostino · 2022 · Free Radical Biology and Medicine
  64. Dual modulation of amyloid beta and tau aggregation and dissociation in Alzheimer’s disease: a comprehensive review of the characteristics and therapeutic strategies
    Yunkwon Nam, Soo Jung Shin, Vijay Kumar, Jihyeon Won, Sujin Kim, Minho Moon · 2025 · Translational Neurodegeneration
  65. Dual role of microglia in neuroinflammation and neurodegenerative diseases
    Amir Ajoolabady, Bonglee Kim, Altaf A. Abdulkhaliq, Jun Tao Ren, Suhad Bahijri, Jaakko O. Tuomilehto, Anwar Borai, Johra Khan, Domenico Praticò · 2025 · Neurobiology of Disease
  66. Progressive Age-Related Cognitive Decline in Tau Mice
    Ann Van der Jeugd, Ben Vermaercke, Maxime J. Derisbourg, Adrian C. Lo, Malika Hamdane, David L Blum, Luc Buée, Rudi D’Hooge · 2013 · Journal of Alzheimer s Disease
  67. Drosophila melanogaster: Deciphering Alzheimer's Disease
    Florence Hui Ping Tan, Ghows Azzam · 2017 · Malaysian Journal of Medical Sciences
  68. Histological and imunohistochemical alterations of hippocampus and prefrontal cortex in a rat model of Alzheimer like-disease with a preferential role of the flavonoid “hesperidin”
    Dalia A. Mandour, Mohamed Bendary, Amira Ebrahim Alsemeh · 2021 · Journal of Molecular Histology
  69. Ribosylation triggering A lzheimer's disease‐like T au hyperphosphorylation via activation of C a MKII
    Wei Yan, Chanshuai Han, Yujing Wang, Beibei Wu, Tao Su, Ying Liu, Rongqiao He · 2015 · Aging Cell
  70. Lipidomics of Alzheimer’s Disease
    David Touboul, Mathieu Gaudin · 2014 · Bioanalysis
  71. Cytokine signaling convergence regulates the microglial state transition in Alzheimer’s disease
    Shun‐Fat Lau, Amy K.Y. Fu, Nancy Y. Ip · 2021 · Cellular and Molecular Life Sciences
  72. Microtubule Defects and Neurodegeneration
    Fiona J. Baird · 2013 · Journal of Genetic Syndromes & Gene Therapy
  73. Post-translational modifications of tau protein
    Miroslava Pevalova, Peter Filipčík, M Novák, Jesús Ávila, K Iqbal · 2006 · Bratislavské lekárske listy/Bratislava medical journal
  74. miRNAs as Therapeutic Tools in Alzheimer’s Disease
    Chang Youn Lee, In Soo Ryu, Jin‐Hyeob Ryu, Hyun‐Jeong Cho · 2021 · International Journal of Molecular Sciences
  75. Probable Participation of 14-3-3 in Tau Protein Oligomerization and Aggregation
    Nikolai N. Sluchanko, Nikolai B. Gusev · 2011 · Journal of Alzheimer s Disease
  76. Over activation of hippocampal serine/threonine protein phosphatases PP1 and PP2A is involved in lead-induced deficits in learning and memory in young rats
    Abdur Rahman, Khalid M. Khan, Ghanim Al‐Khaledi, Islam Khan, Tahany E. Al-Shemary · 2012 · NeuroToxicology
  77. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation
    Kailie Luan, Jesusa L. Rosales, Ki‐Young Lee · 2012 · Ageing Research Reviews
  78. Zinc Exacerbates Tau Pathology in a Tau Mouse Model
    Kristen M Craven, William Kochen, C. M. Hernandez, J. M. Flinn · 2018 · Journal of Alzheimer's Disease
  79. Peripheral immune system and neuroimmune communication impairment in a mouse model of Alzheimer's disease
    Lydia Giménez‐Llort, Ianire Maté, Rashed Manassra, Carmen Vida, Mónica De la Fuente · 2012 · Annals of the New York Academy of Sciences
  80. A Unified Hypothesis of Early- and Late-Onset Alzheimer’s Disease Pathogenesis
    Craig Atwood, Richard L. Bowen · 2015 · Journal of Alzheimer s Disease
  81. Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease
    Beck, Tim N., Nicolas, Emmanuelle, Kopp, Meghan C., Golemis, Erica A. · 2014 · Oncoscience
  82. Human TAUP301L overexpression results in TAU hyperphosphorylation without neurofibrillary tangles in adult zebrafish brain
    Mehmet İlyas Coşacak, Prabesh Bhattarai, Ledio Bocova, Tim Dzewas, Violeta Mashkaryan, Christos Papadimitriou, Kerstin Brandt, Heike Hollak, Christopher L. Antos, Çağhan Kızıl · 2017 · Scientific Reports
  83. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets
    Pei, Jin-Jing, Sjögren, Magnus, Winblad, Bengt · 2008 · Current Opinion in Psychiatry
  84. Histone deacetylase-6 modulates Tau function in Alzheimer's disease
    Tazeen Qureshi, Subashchandrabose Chinnathambi · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  85. A Ce-MOF as an alkaline phosphatase mimic: Ce-OH 2 sites in catalytic dephosphorylation
    Sudip S. Bhattacharjee, Tonmoy Chakraborty, Asim Bhaumik · 2022 · Inorganic Chemistry Frontiers
  86. Novel neuroprotective, neuritogenic and anti-amyloidogenic properties of 2,4-dinitrophenol: The gentle face of Janus
    Fernanda G. De Felice, Sergio Teixeira Ferreira · 2006 · IUBMB Life
  87. Lead Dysregulates Serine/Threonine Protein Phosphatases in Human Neurons
    Abdur Rahman, Bruce James Brew, Gilles J. Guillemin · 2010 · Neurochemical Research
  88. Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1
    Ziran Wang, Hongyan Lei, Mei Zheng, Yuxin Li, Yansen Cui, Fang Hao · 2015 · Molecular Neurobiology
  89. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease
    Hye-Jin Park, Kang-Woo Lee, Stephanie E. Oh, Run Yan, Jie Zhang, Thomas G. Beach, Charles H. Adler, Michael V. Voronkov, Steven P. Braithwaite, Jeffry B. Stock et al. · 2017 · Journal of Neuropathology & Experimental Neurology
  90. Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton
    Alessio Malacrida, C Meregalli, Virginia Rodriguez‐Menendez, Gabriella Nicolini · 2019 · International Journal of Molecular Sciences
  91. Early Cognitive and Behavioral Deficits in Mouse Models for Tauopathy and Alzheimer’s Disease
    Celine Samaey, An Schreurs, Stijn Stroobants, Detlef Balschun · 2019 · Frontiers in Aging Neuroscience
  92. Protein Misfolding during Pregnancy: New Approaches to Preeclampsia Diagnostics
    Elizaveta M. Gerasimova, Sergey A. Fedotov, Daniel V. Kachkin, Elena S. Vashukova, Andrey Sergeyevich Glotov, Yury O. Chernoff, Aleksandr A. Rubel · 2019 · International Journal of Molecular Sciences
  93. Graphene FET Sensors for Alzheimer’s Disease Protein Biomarker Clusterin Detection
    Theodore Bungon, Carrie Haslam, Samar Damiati, Benjamin O’Driscoll, Toby Whitley, Paul Davey, Giuliano Siligardi, Jérôme Charmet, S.A. Awan · 2021 · Frontiers in Molecular Biosciences
  94. Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
    Isabelle Aillaud, Susanne Aileen Funke · 2022 · Cellular and Molecular Neurobiology
  95. Is there a neuropathology difference between mild cognitive impairment and dementia?
    Vahram H. Haroutunian, Lisa B. Hoffman, Michal Schnaider Been · 2009 · Dialogues in Clinical Neuroscience
  96. Trans-cinnamaldehyde improves neuroinflammation-mediated NMDA receptor dysfunction and memory deficits through blocking NF-κB pathway in presenilin1/2 conditional double knockout mice
    Yang Zhao, Haiyan Deng, Kun Li, Lijun Wang, Yongkang Wu, Xianwen Dong, Xingyu Wang, Yongjun Chen, Ying Xu · 2019 · Brain Behavior and Immunity
  97. Dual-Selective Catalysis in Dephosphorylation Tuned by Hf6‑Containing Metal–Organic Frameworks Mimicking Phosphatase
    Jie Dong, Hongde An, Ze-Kun Yue, Sheng‐Li Hou, Yao Chen, Zhenjie Zhang, Peng Cheng, Qian Peng, Bin Zhao · 2021 · ACS Central Science
  98. Dynamic interactions and Ca2+-binding modulate the holdase-type chaperone activity of S100B preventing tau aggregation and seeding
    Guilherme G. Moreira, François‐Xavier Cantrelle, Andrea Quezada, Filipa Sofia Carvalho, Joana S. Cristóvão, Urmi Sengupta, Nicha Puangmalai, Ana P. Carapeto, Mário S. Rodrigues, Isabel Cardoso et al. · 2021 · Nature Communications
  99. Molecular hairpin: a possible model for inhibition of tau aggregation by tannic acid.
    Jun-Liang Yao, Xing Gao, Wen-Liang Sun, Tian-Ming Yao, Shuo Shi, L. Ji · 2013 · Biochemistry
  100. Photodynamic exposure of Rose-Bengal inhibits Tau aggregation and modulates cytoskeletal network in neuronal cells
    Tushar Dubey, Nalini Vijay Gorantla, Kagepura Thammaiah Chandrashekara, Subashchandrabose Chinnathambi · 2020 · Scientific Reports